Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer
- PMID: 954013
Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer
Abstract
The Southwest Oncology Group has confirmed the superiority of 5-fluorouracil (5-FU) and methyl-CCNU versus 5-FU weekly as treatment for patients with advanced gastrointestinal cancers. The drug combination produced a PR rate of 29.3% compared to the single-drug arm rate of 10.6%; however, the two-drug arm produced much more toxicity. Despite the improved response rate no improvement in survival was observed.
Similar articles
-
A controlled study of 5-fluorouracil versus 5-fluorouracil and methyl-CCNU in advanced gastrointestinal adenocarcinoma.Clin Oncol. 1977 Sep;3(3):247-57. Clin Oncol. 1977. PMID: 334430 Clinical Trial. No abstract available.
-
Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer.Cancer Treat Rep. 1976 Jun;60(6):769-80. Cancer Treat Rep. 1976. PMID: 782699 Clinical Trial.
-
[Treatment of advanced digestive cancer with fluorouracil and methyl-CCNU].Acta Gastroenterol Latinoam. 1978;8(3):191-3. Acta Gastroenterol Latinoam. 1978. PMID: 747086 Spanish.
-
Possibilities and limitations of the cytostatic treatment of gastrointestinal carcinoma.Hepatogastroenterology. 1982 Jun;29(3):130-3. Hepatogastroenterology. 1982. PMID: 7049880 Review. No abstract available.
-
Methyl-CCNU inclinical cancer therapy.Cancer Treat Rev. 1974 Dec;1(4):251-69. doi: 10.1016/s0305-7372(74)80018-6. Cancer Treat Rev. 1974. PMID: 4377543 Review. No abstract available.
Cited by
-
Clinical trials in colorectal cancer: experience of the Gastrointestinal Tumor Study Group and the Southwest Oncology Group.Int J Colorectal Dis. 1987 Jun;2(2):100-6. doi: 10.1007/BF01647701. Int J Colorectal Dis. 1987. PMID: 3305744 Clinical Trial.
-
Update in cancer chemotherapy: gastrointestinal cancer--colorectal cancer, Part 2.J Natl Med Assoc. 1986 May;78(5):395-408. J Natl Med Assoc. 1986. PMID: 3519988 Free PMC article. Clinical Trial.
-
Improved combination chemotherapy in advanced gastric cancer.Br Med J. 1979 Dec 8;2(6203):1471-3. doi: 10.1136/bmj.2.6203.1471. Br Med J. 1979. PMID: 526814 Free PMC article.
-
Performance Status in Cancer: Not Broken, But Time for an Upgrade?J Clin Oncol. 2020 Sep 1;38(25):2824-2829. doi: 10.1200/JCO.20.00721. Epub 2020 Jun 25. J Clin Oncol. 2020. PMID: 32584631 Free PMC article. No abstract available.
-
Chemotherapy and radiotherapy for advanced pancreatic cancer.Cochrane Database Syst Rev. 2018 Mar 20;3(3):CD011044. doi: 10.1002/14651858.CD011044.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2024 Dec 5;12:CD011044. doi: 10.1002/14651858.CD011044.pub3. PMID: 29557103 Free PMC article. Updated.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials